Velorum Therapeutics Analysis
What is Velorum Therapeutics?
Velorum Therapeutics develops innovative therapies targeting heme biology to address unmet medical needs in diseases like porphyrias and cancer.
Founded
2023
Revenue
<$5M
Company Stage
Seed
YC Batch
W24
Product Features & Capabilities
- cancer therapies targeting metabolic vulnerabilities, innovative treatments for porphyrias, drugs that disrupt tumor metabolism, therapies that unlock the biology of heme
Who are the founders of Velorum Therapeutics
PM
Pouya Modareszadeh
Co-Founder & CEO
PM
Parsa Modareszadeh
Co-Founder and President
Investors
- Y Combinator
- Ritual Capital
- Metaplanet Holdings
- Transpose Platform Management
Find more companies like Velorum Therapeutics
See something that needs updating? Suggest edits to this profile.
